SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
OSI Pharmaceuticals (OSIP) - formerly Oncogene
An SI Board Since December 1997
Posts SubjectMarks Bans Symbol
447 40 0 OSIP
Emcee:  James Reynolds Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
322QLTI CC post-mortem; 1. Visudyne sales in the U.S. are being hurt by off-label DewDiligence_on_SI-12/8/2005
321>>MELVILLE, N.Y.--(BUSINESS WIRE)--Dec. 8, 2005--OSI Pharmaceuticals, Inc.tuck-12/8/2005
320[Response of Some SCCHNs to EGFR-TKIs May Be Linked to Mutation of ERBB2 rather tuck-11/21/2005
319Thanks, Latest script data confirm my concern that Tarceva will have hard time Miljenko Zuanic-11/15/2005
318I’m thinking that part of the economic rationale for the deal is that OSIP is plDewDiligence_on_SI-11/14/2005
317Actually listened to the CC myself. Not sure what the Yahoo poster that dissed tuck-11/14/2005
316Scrip data courtesy of Ricardouno of the YMB (and I should thank Dew for the poituck-11/14/2005
315<i>OSIP: I sure misread this one. Felt confident that deal was off or at lDewDiligence_on_SI-11/13/2005
314OSIP: I sure misread this one. Felt confident that deal was off or at least termfred hayes-11/13/2005
313OSI Pharmaceuticals and Eyetech Pharmaceuticals Confirm November 14th Closing Sascaram(o)uche-11/12/2005
312WSJ online: online.wsj.comJoe Wesley-11/10/2005
311Tuck: You are correct. Sure looks like it's trading. Maybe the halt has comefred hayes-11/10/2005
310Some detail... Message 21873415FiloF-11/10/2005
309tuck: source is briefing.com but I didn't verify it was in fact halted. finfred hayes-11/10/2005
308Damn - I was thinking about buying some OSIP. May have missed a chance for a niFiloF-11/10/2005
307It's still going up and down on my screen, Fred, what's your source? Edtuck-11/10/2005
306Here we go. OSIP halted. BD making noise about reviewing EYET transaction. I thifred hayes-11/10/2005
305Musings on Lucentis ANCHOR: investorshub.com investorshub.comDewDiligence_on_SI-11/7/2005
304Lucentis ANCHOR data looks pretty good, though we didn't get specific numbertuck-11/7/2005
303Colin Goddard: There's an outstanding question, one that absolutely fascinascaram(o)uche-11/3/2005
302Interesting optic blog with messages from Dr. Folk and Macugen problems. medroJoe Wesley-10/28/2005
301Contrary to RCC regime, DNA is running PIII NSCLC (second line) where Tarceva isMiljenko Zuanic-10/27/2005
300Tarceva adds no benefit to Avastin in metastatic RCC: >>SOUTH SAN FRANCIStuck-10/18/2005
299<i>stuff like "This merger saved my *ss." doesn't make it toDewDiligence_on_SI-10/17/2005
298<i>Doses range ratio of 1 : 100, in PIII???? Wow!</i> In the phase-DewDiligence_on_SI-10/17/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News